[{"Assets_0_Q1_USD":2013999000.0,"CommonStockSharesOutstanding_0_Q1_shares":106400000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-188510000.0,"NetIncomeLoss_1_Q1_USD":-181915000.0,"StockholdersEquity_0_Q1_USD":1546986000.0,"Ticker":"ALNY","CIK":"1178670","name":"ALNYLAM PHARMACEUTICALS, INC.","OfficialName":"Alnylam Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"19459816074.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190502"}]